Synaptec Ltd - Accounts to registrar (filleted) - small 18.2

Synaptec Ltd - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v21.4.0.171 SC472060 Board of Directors 1.1.21 31.12.21 31.12.21 21.4.22 false true false false true false Auditors Opinion Ordinary 0.0100 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC4720602020-12-31SC4720602021-12-31SC4720602021-01-012021-12-31SC4720602019-12-31SC4720602020-01-012020-12-31SC4720602020-12-31SC472060ns16:Scotland2021-01-012021-12-31SC472060ns15:PoundSterling2021-01-012021-12-31SC472060ns11:Director12021-01-012021-12-31SC472060ns11:PrivateLimitedCompanyLtd2021-01-012021-12-31SC472060ns11:SmallEntities2021-01-012021-12-31SC472060ns11:Audited2021-01-012021-12-31SC472060ns11:SmallCompaniesRegimeForDirectorsReport2021-01-012021-12-31SC472060ns11:SmallCompaniesRegimeForAccounts2021-01-012021-12-31SC472060ns11:FullAccounts2021-01-012021-12-31SC472060ns11:OrdinaryShareClass12021-01-012021-12-31SC472060ns11:Director22021-01-012021-12-31SC472060ns11:Director32021-01-012021-12-31SC472060ns11:Director42021-01-012021-12-31SC472060ns11:Director52021-01-012021-12-31SC472060ns11:Director62021-01-012021-12-31SC472060ns11:CompanySecretary12021-01-012021-12-31SC472060ns11:RegisteredOffice2021-01-012021-12-31SC472060ns6:CurrentFinancialInstruments2021-12-31SC472060ns6:CurrentFinancialInstruments2020-12-31SC472060ns6:Non-currentFinancialInstruments2021-12-31SC472060ns6:Non-currentFinancialInstruments2020-12-31SC472060ns6:ShareCapital2021-12-31SC472060ns6:ShareCapital2020-12-31SC472060ns6:SharePremium2021-12-31SC472060ns6:SharePremium2020-12-31SC472060ns6:FurtherSpecificReserve3ComponentTotalEquity2021-12-31SC472060ns6:FurtherSpecificReserve3ComponentTotalEquity2020-12-31SC472060ns6:RetainedEarningsAccumulatedLosses2021-12-31SC472060ns6:RetainedEarningsAccumulatedLosses2020-12-31SC472060ns6:PlantMachinery2020-12-31SC472060ns6:ComputerEquipment2020-12-31SC472060ns6:PlantMachinery2021-01-012021-12-31SC472060ns6:ComputerEquipment2021-01-012021-12-31SC472060ns6:PlantMachinery2021-12-31SC472060ns6:ComputerEquipment2021-12-31SC472060ns6:PlantMachinery2020-12-31SC472060ns6:ComputerEquipment2020-12-31SC472060ns6:CostValuation2020-12-31SC472060ns6:WithinOneYearns6:CurrentFinancialInstruments2021-12-31SC472060ns6:WithinOneYearns6:CurrentFinancialInstruments2020-12-31SC472060ns6:BetweenTwoFiveYearsns6:Non-currentFinancialInstruments2021-12-31SC472060ns6:BetweenTwoFiveYearsns6:Non-currentFinancialInstruments2020-12-31SC472060ns6:BetweenOneFiveYears2021-12-31SC472060ns6:BetweenOneFiveYears2020-12-31SC472060ns11:OrdinaryShareClass12021-12-31SC472060ns6:FurtherSpecificReserve3ComponentTotalEquity2020-12-31
REGISTERED NUMBER: SC472060 (Scotland)















Financial Statements for the Year Ended 31 December 2021

for

Synaptec Ltd

Synaptec Ltd (Registered number: SC472060)






Contents of the Financial Statements
for the Year Ended 31 December 2021




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Synaptec Ltd

Company Information
for the Year Ended 31 December 2021







DIRECTORS: P J G Orr
Dr C Booth
N A Ellis
Dr P Niewczas
D C N Pratt
T G McKinstry





SECRETARY: P J G Orr





REGISTERED OFFICE: 120 Bothwell Street
Glasgow
G2 7JL





REGISTERED NUMBER: SC472060 (Scotland)





AUDITORS: Johnston Carmichael LLP
227 West George Street
Glasgow
G2 2ND

Synaptec Ltd (Registered number: SC472060)

Statement of Financial Position
31 December 2021

31.12.21 31.12.20
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 101,295 49,592
Investments 5 250 250
101,545 49,842

CURRENT ASSETS
Stocks 273,835 105,253
Debtors 6 565,604 291,669
Cash at bank 1,628,851 2,404,135
2,468,290 2,801,057
CREDITORS
Amounts falling due within one year 7 128,394 73,471
NET CURRENT ASSETS 2,339,896 2,727,586
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,441,441

2,777,428

CREDITORS
Amounts falling due after more than one
year

8

415,512

215,760
NET ASSETS 2,025,929 2,561,668

CAPITAL AND RESERVES
Called up share capital 11 239 239
Share premium 3,215,788 3,215,788
Share based payments reserve 12 83,758 20,839
Retained earnings (1,273,856 ) (675,198 )
SHAREHOLDERS' FUNDS 2,025,929 2,561,668

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 April 2022 and were signed on its behalf by:





P J G Orr - Director


Synaptec Ltd (Registered number: SC472060)

Notes to the Financial Statements
for the Year Ended 31 December 2021

1. STATUTORY INFORMATION

Synaptec Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

Turnover
Turnover represents income from the sale of the company's products and is recognised at the fair value of the consideration received or receivable for goods provided in the normal course of business. Turnover is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer, the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Where product sales include predetermined milestones such as product testing or installation, turnover is recognised on completion of these milestones.

Tangible fixed assets
Tangible fixed assets are stated at historical cost less accumulated depreciation and any impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged to profit or loss over the estimated useful life economic lives as follows-

-Plant and machinery- Over 5 years on straight line basis
-Computer and equipment- 33% on cost.

Basic financial liabilities
Basic financial liabilities, including certain creditors and other loans, are initially recognised at transaction price. Financial liabilities classified as payable within one year are not amortised. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Investments in subsidiaries
Investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals or impairment losses are recognised immediately in the profit and loss account.

Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost includes expenditure incurred in acquiring the stocks, production or conversion costs and other costs in bringing them to their existing location and condition .

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its estimated selling price less costs to complete and sell. The impairment is recognized immediately within profit and loss.

Synaptec Ltd (Registered number: SC472060)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2021

2. ACCOUNTING POLICIES - continued

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Research and Development tax credits are recognised at the fair value of the asset received or receivable when there is reasonable assurance that claims will be successful.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Foreign currencies
Transactions in foreign currencies are translated to the company's functional currency at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the balance sheet date are retranslated to the functional currency at the foreign exchange rate ruling at that date. Foreign exchange differences arising on translation are recognized in profit or loss.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Government grants
Government grants are recognsied at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

Government grants relating to turnover are recognised as income over the periods when the related costs are incurred.

Synaptec Ltd (Registered number: SC472060)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2021

2. ACCOUNTING POLICIES - continued

Going concern
The directors believe the company has adequate resources to continue in operational existence for the foreseeable future, being a period of at least 12 months from the signing of the financial statements.

In forming this assessment, the directors have considered existing company resources as well as trading and cash flows projections. The company is entering a scale-up phase that will require additional investment to achieve its strategic objectives. The timing at which future investment is required could be within the next 12 months. Whilst there are no guarantees that investment could be raised within the next 12 months, the directors are confident they can manage the pace of scale-up and continue to meet the company's financial obligations from existing cash reserves in the event no additional investment is raised in the next 12 months.

Based on the factors above, the directors deem it appropriate to continue to prepare the financial statements on a going concern basis.

Share-based payments
Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted. Where material, the fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 20 (2020 - 16 ) .

4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 January 2021 80,417 9,634 90,051
Additions 68,153 10,778 78,931
At 31 December 2021 148,570 20,412 168,982
DEPRECIATION
At 1 January 2021 35,062 5,397 40,459
Charge for year 22,894 4,334 27,228
At 31 December 2021 57,956 9,731 67,687
NET BOOK VALUE
At 31 December 2021 90,614 10,681 101,295
At 31 December 2020 45,355 4,237 49,592

Synaptec Ltd (Registered number: SC472060)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2021

5. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 January 2021
and 31 December 2021 250
NET BOOK VALUE
At 31 December 2021 250
At 31 December 2020 250

Synaptec Ltd is the ultimate group holding company of the Synaptec Group. Synaptec Ltd has one wholly owned subsidiary, Synaptec Instruments Ltd SC684349, registered in Scotland. Synaptec Instruments Ltd is currently dormant.

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.21 31.12.20
£    £   
Trade debtors 249,424 48,936
Other debtors 1,208 -
Accrued income 116,606 39,427
Tax 186,275 166,932
VAT 5,358 19,840
Prepayments 6,733 16,534
565,604 291,669

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.21 31.12.20
£    £   
Trade creditors 59,906 18,729
Social security and other taxes 25,733 19,503
Other creditors 10,957 250
Accruals and deferred income 31,798 34,989
128,394 73,471

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.12.21 31.12.20
£    £   
Other loans (see note 9) 221,512 215,760
Accruals and deferred income 194,000 -
415,512 215,760

Synaptec Ltd (Registered number: SC472060)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2021

9. LOANS

An analysis of the maturity of loans is given below:

31.12.21 31.12.20
£    £   
Amounts falling due between two and five years:
Other loans - 2-5 years 221,512 215,760

10. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
31.12.21 31.12.20
£    £   
Between one and five years - 14,580

11. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal 31.12.21 31.12.20
value: £    £   
238,571 Ordinary £0.00 1 239 239

The company operates an equity settled EMI Share Option Scheme. During the year, 1,100 (2020 - 2,480) share options were granted to employees by the company. At 31 December 2021, the total number of options outstanding under the scheme was 8,214 (2020 - 7,114) with an exercise price raging between £12.48 and £37.28. The share options vest on their grant date but can only be exercised on certain exit events or at the discretion of the board.

12. RESERVES
Share
based
payments
reserve
£   
At 1 January 2021 20,839
Credit to equity for equity settled share
based payment transactions

62,919


At 31 December 2021 83,758

13. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

James Hamilton (Senior Statutory Auditor)
for and on behalf of Johnston Carmichael LLP